BCL2 and cancer: Other researchers who used Bcl-2-targeted siRNA also observed consistent anti-cancer effects upon Bcl-2 gene silencing, indicating that the Bcl-2 antisense therapy is one of the most fruitful strategies to induce apoptosis in cancer cells [66,67].